Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders

Nov. 22, 2013

European Commission approves Prilocaine Lidocaine Plethora for premature ejaculation

Nov. 19, 2013

Toray Industries divulges novel soluble epoxide hydrolase inhibitors

Nov. 18, 2013

Kyowa Hakko Kirin discontinues phase II studies of bardoxolone methyl

Nov. 12, 2013

Keryx Biopharmaceuticals provides update from safety extension study of Zerenex

Nov. 12, 2013

New Hsp70 inducers presented by scientists in the Netherlands

Nov. 11, 2013

Phase II trial of Zerenex in NDD-CKD meets all primary and key secondary endpoints

Nov. 7, 2013

Genkyotex begins multinational phase II study of NOX inhibitor

Nov. 5, 2013

Development of Kremezin discontinued in the U.S. and Europe

Oct. 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...